top of page
Topic: Head and Neck cancer
CPGs graded Strong
Grégoire V, Leroy R et al. (2015). Oropharyngeal, hypopharyngeal and laryngeal cancer: diagnosis, treatment and follow-up. Good Clinical Practice (GCP) Brussels: Belgian Health Care Knowledge Centre (KCE). 2015. KCE Reports 256. D/2015/10.273/105.
Grégoire V, Leroy R et al. (2015). Oral cavity cancer: diagnosis, treatment and follow-up – Abstract. Good Clinical Practice (GCP) Brussels: Belgian Health Care Knowledge Centre (KCE). 2014. KCE Reports 227Cs. D/2014/10.273/57.
Wolff K.-D., Bootz F et al. (2012). Diagnosis and Management of Carcinoma of the Oral Cavity. AWMF Registry Number 007/100OL Version 2.0 - November 2012. https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Mundhoehlenkarzinom/GGPO_OralCavity_Short.pdf 
Durbec M, Couloigner V et al.(2014). Guidelines of the French Society of Otorhinolaryngology (SFORL), short version. Extension assessment and principles of resection in cutaneous head and neck tumors. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Dec;131(6):375-383. doi: 10.1016/j.anorl.2014.06.002.
Espitalier F, Testelin S et al. (2014). Management of somatic pain induced by treatment of head and neck cancer: Postoperative pain. Guidelines of the French Oto-RhinoLaryngology – Head and Neck Surgery Society (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Sep;131(4):249-52. doi: 10.1016/j.anorl.2014.05.002. Epub 2014 Aug 5. 
Maubec E, Lamas G et al. (2017). Recommandation pour la pratique clinique: Prise en charge des patients atteints de tumeur de la face et du cou à point de départ cutané. Société Française d’Oto-Rhino-Laryngologie et de Chirurgie. https://www.orlfrance.org/wp-content/uploads/2017/06/Recommandation_prise_en_charge_des_patients_immunodeprimes_2013_V2.pdf
Disant F, Albert S et al. (2013). Recommandation pour la pratique clinique: Bilan d’extension et principes d’exérèse des tumeurs de la face et du cou à point de départ cutané. Annales Françaises d'Oto-Rhino-Laryngologie et de pathologie cervico-faciale
Volume 131, n° 6; pages 360-369 (décembre 2014). doi : 10.1016/j.aforl.2014.10.001. https://www.orlfrance.org/wp-content/uploads/2017/06/Recommandation_Bilan_extension_Principe_exerese_tumeur_-face_cou_point_depart_cutane_2013.pdf
Blanchard D, Bollet M et al (2014). Management of somatic pain induced by head and neck cancer treatment: Pain following radiation therapy and chemotherapy. Guidelines of the French Otorhinolaryngology Head and Neck. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Sep;131(4):253-6. doi: 10.1016/j.anorl.2014.07.001. Epub 2014 Aug 4.
Licitra L, Baldi G, Alterio D et al.(2016). Guidelines Head and neck cancers ( Linee guida Tumori della testa e del collo). Italian Association of Medical Oncology (AIOM)
Paleri V, Roland N (2016). Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of Laryngology & Otology (2016), 130 (Suppl. S2) . 
https://www.cambridge.org/core/services/aop-file-manager/file/57fbbd73983d5b2b18ef2ac9/JLO-Head-and-Neck-Single-File.pdf
CPGs graded Moderate
Deneuve S, Babin E et al. (2015).Guidelines (short version) of the French Otorhinolaryngology – Head and Neck Surgery Society (SFORL) on patient pathway organization in ENT: The therapeutic decision-making process, European Annals of Otorhinolaryngology, Head and Neck Diseases,Volume 132, Issue 4; https://doi.org/10.1016/j.anorl.2015.06.006
Müller-Richter U et al.(2017). Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment. Ann Surg Oncol. 2017; 24(11): 3430–3437. doi: 10.1245/s10434-017-5993-1
Weichert W et al. (2017). S1-Leitlinie zur pathologisch-anatomischen Diagnostik von Plattenepithelkarzinomen des Kopf-Hals-Bereiches /(S1 Guideline for pathologic anatomical Diagnostics of squamous cell carcinomas of Head and Neck).  http://www.pathologie.net/fileadmin/user_upload/Fassung__S1-Leitlinie_Kopf-Hals_Karzinome_1_17.PDF
Mirabile A , Airoldi M et al. (2016). Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations. Crit Rev Oncol Hematol. 2016 Mar;99:100-6. doi: 10.1016/j.critrevonc.2015.11.010. Epub 2015 Dec 3.
Pastor M et al.(2017). SEOM clinical guideline in nasopharynx cancer. Clin Transl Oncol (2018) 20:84–88  doi: 10.1007/s12094-017-1777-0
Iglesias D LC, Arrula VA et al.(2017). SEOM clinical guidelines for the treatment of head and neck cancer. Clin Transl Oncol (2018) 20:75–83. doi: 10.1007/s12094-017-1776-1
Mesía R., Pastor M. et al. (2013). SEOM clinical guidelines for the treatment of head and neck cancer (HNC). Clin Transl Oncol. 2013 Dec;15(12):1018-24. doi: 10.1007/s12094-013-1096-z. Epub 2013 Aug 27.
Cabrera R J, Cacicedo J et al. (2018). GEORCC recommendations on target volumes in radiotherapy for Head Neck Cancer of Unkown Primary. Crit Rev Oncol Hematol. 2018 Oct;130:51-59. doi: 10.1016/j.critrevonc.2018.07.006. Epub 2018 Jul 24.
Janot F, Zanaret M et al. (2010). Recommandation pour la Pratique Clinique: G1 - Tumeurs malignes primitives des fosses nasales et des sinus (G1 - Primary malignant tumours of the nasal cavities and sinuses). Réseau d’Expertise. Update 2017. https://www.orlfrance.org/wp-content/uploads/2017/06/Refcor_SINUS.pdf
Bensadoun RJ, Lacau St Guily J et al. (2010). Recommandation pour la Pratique Clinique : G4 – Tumeurs malignes primitives des glandes salivaires (G4 - Primary malignant tumours of the salivary glands). Réseau d’Expertise Français sur les Cancers ORL. Update 2017. http://refcor.org/files/81/G4-glandes-salivaires-argumentaire2.pdf
Bejar C, Basset-Seguin N et al. (2014). French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Apr;131(2):121-9. doi: 10.1016/j.anorl.2014.02.002. Epub 2014 Mar 19.
Blanchard D, Barry B, D. De Raucourt D et al. (2015). Guidelines update: Post-treatment follow-up of adult head and neck squamous cell carcinoma: Screening for metastasis and metachronous esophageal and bronchial locations. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Sep;132(4):217-21. doi: 10.1016/j.anorl.2015.07.001. Epub 2015 Aug 18.
Schethenbach K et al. (2012). Squamous Cell Carcinomas of the Head and Neck in Fanconi Anemia: Risk, Prevention, Therapy, and the Need for Guidelines. Klin Padiatr. 2012 Apr; 224(3): 132–138. doi: 10.1055/s-0032-1308989
Reyt E, Sterkers O et al.(2010). Recommandation pour la Pratique Clinique: G2 - Tumeurs malignes primitives de l’oreille (G2 - Primary malignant tumours of the ear). Update 2017. https://www.orlfrance.org/wp-content/uploads/2017/06/Refcor_Oreille.pdf
Merlotti A, Alterio D et al.(2014). Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group. Radiat Oncol. 2014 Dec 29;9:264. doi: 10.1186/s13014-014-0264-9; Update 2017
NICE guideline Committee (2016). Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over (NICE guideline [NG36]). Update 2018. https://www.nice.org.uk/guidance/ng36/evidence/full-guideline-2307980269
National Health Service (NHS)(2016). Head and Neck Cancer Management Guideline. Update 2018. https://www.nwcscnsenate.nhs.uk/files/3514/7317/7153/Head_and_Neck_Cancer_Network_Management_Guidelines._Version_1.2016.pdf
Chan ATC, Grégoire V, Lefebvre JL et al. (2012). Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 23 (Supplement 7): vii83–vii85, 2012 doi:10.1093/annonc/mds266. https://academic.oup.com/annonc/article/23/suppl_7/vii83/144862
Reich, M., et al. (2016). Best practice guidelines in the psychosocial management of HPVrelated head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense Campaign. Annals of Oncology, Volume 27, Issue 10, October 2016, Pages 1848–1854,https://doi.org/10.1093/annonc/mdw272
Bacciu A, Piccirillo E et al. (2013). Guidelines for Treating Temporal Bone Carcinoma Based on Long term Outcomes. Otol Neurotol. 2013 Jul;34(5):898-907. doi: 10.1097/MAO.0b013e318281e0a9.
Morinière s , Albert S et al.(2014). Recommandation pour la Pratique Clinique (RPC): Prise en charge des douleurs somatiques induites par les traitements des cancers des VADS. Update 2017. https://www.orlfrance.org/wp-content/uploads/2017/06/Recommandation_Prise_en_charge_douleurs_induites_par_traitement_des_cancer_VADS_2014.pdf
Unbenannt.JPG

Work Package 6

_project_management_standards.jpg

Tasks of work package 6

​

  • Map available clinical practice guidelines (CPGs) at the European level on all families of rare cancers and identify gaps

  • Quality evaluation of existing guidelines for rare cancer subtypes  

​

The JARC Work Package 6 maintains this website to share the results of quality evaluation of existing CPGs at European local and national level on rare cancers with partners involved in the EU JARC Project. However, the JARC Work Package 6 does not accept any responsibility or obligation of any kind whatsoever with regard to the information contained on this site.

The  JARC WP 6 Website contains links to other websites.

Not having control over the content of these third-party websites, no responsibility is assumed for their policies or practices.

Therefore, please review the privacy policies of these third-party websites.

Tasks of work package 6

​​

  • Open issues about implementation of CPGs at the local level and their interface with reimbursement systems

  • Work out solutions on how to assess the implementation of CPGs in the context of ERNs and national clinical collaborative networks

bottom of page